Brian J Mog

14PUBLICATIONS
50CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Dec 22, 2025
TRBC2-targeting antibody-drug conjugates for the treatment of T cell cancers.

Jiaxin Ge, Joshua Urban, Sarah R DiNapoli

|Mar 28, 2024
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers.

Tushar D Nichakawade, Jiaxin Ge, Brian J Mog

|Aug 21, 2023
Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen.

Katharine M Wright, Sarah R DiNapoli, Michelle S Miller

|Apr 06, 2023
Improving the sensitivity of in vivo CRISPR off-target detection with DISCOVER-Seq.

Roger S Zou, Yang Liu, Oscar E Reyes Gaido

|Feb 05, 2022
Author Correction: Targeting public neoantigens for cancer immunotherapy.

Alexander H Pearlman, Michael S Hwang, Maximilian F Konig

Pageof 3